Oxford Immunotec Global reported $275K in Operating Profit for its third fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Bruker BRKR:US $ 85.6M 3.5M
Cytori Therapeutics CYTX:US $ -2575000 96K
Edap Tms EDAP:US $ -0.43M 0.67M
Fluidigm FLDM:US -17268000 2.05M
Genmark Diagnostics GNMK:US $ -2.09M 0.82M
Hologic HOLX:US $ 358.6M 438.2M
Illumina ILMN:US $ 187M 6M
Laboratory Of America LH:US $ 704.1M 353.8M
Luminex LMNX:US $ 13.46M 2.96M
Myriad Genetics MYGN:US $ -20.8M 25.9M
Natus Medical BABY:US $ 6.01M 1.49M
Oxford Immunotec Global OXFD:US $ 0.28M 10.11M
Pacific Biosciences Of California PACB:US $ -37.57M 48.14M
Quest Diagnostics DGX:US $ 533M 127M
Quidel QDEL:US $ 23.31M 200.88M
Sientra SIEN:US -9157000 663K
Thermo Fisher Scientific TMO:US $ 2163M 886M
Veracyte VCYT:US $ -7.47M 37.94M
Waters WAT:US $ 196.42M 25.15M